|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 131.59 USD | -1.25% |
|
+4.17% | -7.22% |
| Capitalization | 1.32TCr 1.12TCr 1.03TCr 975.51Cr 1.8TCr 1,22800Cr 1.84TCr 12TCr 4.74TCr 59TCr 4.95TCr 4.85TCr 2,09400Cr | P/E ratio 2026 * |
22.5x | P/E ratio 2027 * | 18.2x |
|---|---|---|---|---|---|
| Enterprise value | 982.65Cr 833.88Cr 764.31Cr 725.83Cr 1.34TCr 91TCr 1.37TCr 8.97TCr 3.53TCr 44TCr 3.69TCr 3.61TCr 1,55800Cr | EV / Sales 2026 * |
2.87x | EV / Sales 2027 * | 3.53x |
| Free-Float |
98.7% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Neurocrine Biosciences, Inc.
| 1 day | -1.25% | ||
| 1 week | +4.17% | ||
| Current month | -0.11% | ||
| 1 month | +3.06% | ||
| 3 months | -2.19% | ||
| 6 months | -6.89% | ||
| Current year | -7.22% |
| 1 week | 127.76 | 134.11 | |
| 1 month | 125.11 | 134.2 | |
| Current year | 122.14 | 142.82 | |
| 1 year | 100.83 | 160.18 | |
| 3 years | 84.23 | 160.18 | |
| 5 years | 71.88 | 160.18 | |
| 10 years | 37.34 | 160.18 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kyle Gano
CEO | Chief Executive Officer | 53 | 11/10/2024 |
| Director of Finance/CFO | 47 | 01/11/2017 | |
Sanjay Keswani
CTO | Chief Tech/Sci/R&D Officer | 56 | 02/06/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Gorman
BRD | Director/Board Member | 68 | 01/01/2008 |
Richard Pops
BRD | Director/Board Member | 64 | 01/04/1998 |
| Chairman | 78 | 01/05/2011 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.25% | +4.17% | +29.80% | +25.85% | 1.32TCr | ||
| -0.77% | -1.04% | +9.52% | +145.43% | 82TCr | ||
| -1.49% | -3.06% | +46.50% | +41.03% | 56TCr | ||
| -2.24% | -1.34% | +17.76% | +25.95% | 36TCr | ||
| -0.91% | +0.88% | +25.20% | +15.27% | 33TCr | ||
| -1.06% | -0.94% | +45.74% | +21.27% | 31TCr | ||
| -1.65% | -2.54% | +50.13% | +2.57% | 29TCr | ||
| -0.83% | -2.43% | +29.42% | +32.00% | 29TCr | ||
| -1.45% | +0.10% | +26.28% | +43.83% | 19TCr | ||
| +0.15% | +5.04% | -33.71% | -55.58% | 18TCr | ||
| Average | -0.77% | +0.45% | +24.66% | +29.76% | 33.45TCr | |
| Weighted average by Cap. | -0.75% | -0.56% | +25.43% | +51.48% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 342.91Cr 291Cr 266.72Cr 253.29Cr 468.11Cr 32TCr 478.09Cr 3.13TCr 1.23TCr 15TCr 1.29TCr 1.26TCr 54TCr | 374.56Cr 317.85Cr 291.34Cr 276.67Cr 511.31Cr 35TCr 522.22Cr 3.42TCr 1.34TCr 17TCr 1.4TCr 1.38TCr 59TCr |
| Net income | 61Cr 52Cr 48Cr 45Cr 84Cr 5.69TCr 85Cr 558.22Cr 219.55Cr 2.75TCr 229.47Cr 224.71Cr 9.7TCr | 76Cr 65Cr 59Cr 56Cr 103.79Cr 7.07TCr 106Cr 693.8Cr 272.87Cr 3.41TCr 285.2Cr 279.28Cr 12TCr |
| Net Debt | -338.03Cr -286.85Cr -262.92Cr -249.68Cr -461.44Cr -31TCr -471.28Cr -3.08TCr -1.21TCr -15TCr -1.27TCr -1.24TCr -54TCr | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | 131.59 $ | -1.25% | 17,75,794 |
| 17/26/17 | 133.25 $ | +3.77% | 17,28,446 |
| 16/26/16 | 128.41 $ | -2.31% | 10,30,447 |
| 15/26/15 | 131.44 $ | +0.48% | 10,98,535 |
| 14/26/14 | 130.81 $ | +3.55% | 11,13,939 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- NBIX Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition

















